227 related articles for article (PubMed ID: 12525538)
1. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC).
Smiraglia DJ; Smith LT; Lang JC; Rush LJ; Dai Z; Schuller DE; Plass C
J Med Genet; 2003 Jan; 40(1):25-33. PubMed ID: 12525538
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
3. CpG islands in MyD88 and ASC/PYCARD/TMS1 promoter regions are differentially methylated in head and neck squamous cell carcinoma and primary lung squamous cell carcinoma.
Šutić M; Baranašić J; Bilić LK; Bilić M; Jakovčević A; Brčić L; Seiwerth S; Jakopović M; Samaržija M; Zechner U; Knežević J
Diagn Pathol; 2021 Feb; 16(1):17. PubMed ID: 33637109
[TBL] [Abstract][Full Text] [Related]
4. Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer.
Takes RP; Baatenburg de Jong RJ; Wijffels K; Schuuring E; Litvinov SV; Hermans J; van Krieken JH
J Pathol; 2001 Jul; 194(3):298-302. PubMed ID: 11439361
[TBL] [Abstract][Full Text] [Related]
5. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression.
Huang Q; Yu GP; McCormick SA; Mo J; Datta B; Mahimkar M; Lazarus P; Schäffer AA; Desper R; Schantz SP
Genes Chromosomes Cancer; 2002 Jun; 34(2):224-33. PubMed ID: 11979556
[TBL] [Abstract][Full Text] [Related]
6. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma.
Lleras RA; Smith RV; Adrien LR; Schlecht NF; Burk RD; Harris TM; Childs G; Prystowsky MB; Belbin TJ
Clin Cancer Res; 2013 Oct; 19(19):5444-55. PubMed ID: 23894057
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
9. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of head and neck squamous cell carcinoma using comparative genomic hybridisation identifies specific aberrations associated with laryngeal origin.
Patmore HS; Ashman JN; Stafford ND; Berrieman HK; MacDonald A; Greenman J; Cawkwell L
Cancer Lett; 2007 Dec; 258(1):55-62. PubMed ID: 17920192
[TBL] [Abstract][Full Text] [Related]
11. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
Tao L; Lefèvre M; Callard P; Périé S; Bernaudin JF; St Guily JL
Otolaryngol Head Neck Surg; 2006 Sep; 135(3):445-50. PubMed ID: 16949980
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive mapping of the methylation landscape of 16 CpG-dense regions in oral and pharyngeal squamous cell carcinoma.
Langevin SM; Kuhnell D; Niu L; Biesiada J; Leung YK; Deka R; Chen A; Medvedovic M; Kelsey KT; Kasper S; Zhang X
Epigenomics; 2019 Jul; 11(9):987-1002. PubMed ID: 31215230
[No Abstract] [Full Text] [Related]
13. The development of CpG island methylation biomarkers using restriction landmark genomic scanning.
Smiraglia DJ; Plass C
Ann N Y Acad Sci; 2003 Mar; 983():110-9. PubMed ID: 12724216
[TBL] [Abstract][Full Text] [Related]
14. LINE-1 and Alu methylation patterns in lymph node metastases of head and neck cancers.
Kitkumthorn N; Keelawat S; Rattanatanyong P; Mutirangura A
Asian Pac J Cancer Prev; 2012; 13(9):4469-75. PubMed ID: 23167363
[TBL] [Abstract][Full Text] [Related]
15. Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype.
Brennan K; Koenig JL; Gentles AJ; Sunwoo JB; Gevaert O
EBioMedicine; 2017 Mar; 17():223-236. PubMed ID: 28314692
[TBL] [Abstract][Full Text] [Related]
16. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis.
Park J; Brena RM; Gruidl M; Zhou J; Huang T; Plass C; Tockman MS
Cancer Biomark; 2005; 1(2-3):193-200. PubMed ID: 17192040
[TBL] [Abstract][Full Text] [Related]
17. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer.
Sharma R; Panda NK; Khullar M
Oral Dis; 2010 Oct; 16(7):668-73. PubMed ID: 20846153
[TBL] [Abstract][Full Text] [Related]
19. Enhanced tumor cell expression of tumor necrosis factor receptors in head and neck squamous cell carcinoma.
von Biberstein SE; Spiro JD; Lindquist R; Kreutzer DL
Am J Surg; 1995 Nov; 170(5):416-22. PubMed ID: 7485723
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
